β-catenin-IN-2

CAS No. 1458664-10-2

β-catenin-IN-2( —— )

Catalog No. M28838 CAS No. 1458664-10-2

β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 215 Get Quote
10MG 340 Get Quote
25MG 575 Get Quote
50MG 822 Get Quote
100MG 1107 Get Quote
500MG 2241 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    β-catenin-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.
  • Description
    β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.(In Vitro):In HCT116 cells, β-catenin-IN-2 (10-40 μM) dose-dependently suppressed the transcriptional activity of the β-catenin/Tcf-4 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    H4 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1458664-10-2
  • Formula Weight
    255.29
  • Molecular Formula
    C15H14FN3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (326.41 mM)
  • SMILES
    CN(C)c(cc1)ccc1-c1nc(ccc(F)c2)c2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sanna MD, et al. Histamine H4 receptor stimulation in the locus coeruleus attenuates neuropathic pain by promoting the coeruleospinal noradrenergic inhibitory pathway. Eur J Pharmacol. 2020 Feb 5;868:172859.
molnova catalog
related products
  • NRX-103094

    NRX-103094 is a potent enhancer of the interaction between β-catenin and the homologous E3 ligase SCFβ-TrCP, increasing the affinity of pSer33/Ser37 β-catenin for β-TrCP with an EC50 of 62 nM and a Kd of 0.6 nM.

  • Miclxin

    Miclxin (DS37262926) is a novel MIC60 inhibitor that induces apoptosis through mitochondrial stress in mutant tumor cells via β-catenin.

  • ICG-001

    ICG-001 is an antagonist of Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM.